We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
STAFFORD, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.36 | -2.47763248451 | 14.53 | 15.19 | 13.2 | 36739 | 14.40724438 | CS |
4 | 0.17 | 1.21428571429 | 14 | 16.5 | 13.1339 | 35934 | 14.35740409 | CS |
12 | -1.28 | -8.28478964401 | 15.45 | 18.15 | 12.75 | 35212 | 15.06831075 | CS |
26 | -3.32 | -18.982275586 | 17.49 | 21.44 | 11.375 | 34345 | 15.2235795 | CS |
52 | 5.17 | 57.4444444444 | 9 | 21.44 | 7.58 | 31922 | 13.73987702 | CS |
156 | -27.1 | -65.6651320572 | 41.27 | 45.23 | 6.8241 | 62924 | 13.9190095 | CS |
260 | 9.17 | 183.4 | 5 | 128 | 3.262 | 132138 | 33.5148467 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions